Current Hematologic Malignancy Reports

, Volume 6, Issue 3, pp 157–163

Primary Mediastinal Large B-Cell Lymphoma, Classic Hodgkin Lymphoma Presenting in the Mediastinum, and Mediastinal Gray Zone Lymphoma: What is the Oncologist To Do?

  • Cliona Grant
  • Kieron Dunleavy
  • Franziska C. Eberle
  • Stefania Pittaluga
  • Wyndham H. Wilson
  • Elaine S. Jaffe
Article

DOI: 10.1007/s11899-011-0090-1

Cite this article as:
Grant, C., Dunleavy, K., Eberle, F.C. et al. Curr Hematol Malig Rep (2011) 6: 157. doi:10.1007/s11899-011-0090-1

Abstract

In recent years, an overlap in biologic and clinical features has been identified between classic Hodgkin lymphoma (CHL) and primary mediastinal large B-cell lymphoma (PMBL). Further strengthening this relationship is the identification of lymphomas with clinical and morphologic features transitional between the two, known as gray zone lymphomas (GZL). However, this diagnostic gray zone is not just of theoretical interest: it presents a practical problem, as the treatment approaches for CHL traditionally differ from those for aggressive B-cell lymphomas. This article reviews the treatment approach for mediastinal lymphomas, including CHL of the nodular sclerosis subtype (CHL-NS), PMBL, and mediastinal GZL. Though several trials have evaluated different regimens with or without radiation in PMBL and CHL-NS, there is a lack of prospective experience in treating GZL because of the rarity of these tumors. Historical data indicate that they have done poorly with traditional approaches developed for the treatment of either CHL or diffuse large B-cell lymphoma.

Keywords

Hodgkin lymphomaHodgkin’s diseaseMediastinal lymphomasPrimary mediastinal large B-cell lymphomaThymic lymphomaDiffuse large B-cell lymphomaDLBCLGray zone lymphomaGrey zone lymphomaEpigeneticsGene expression profilingRadiation therapyChemotherapyImmunophenotypingMicroenvironment

Copyright information

© Springer Science+Business Media, LLC (outside the USA) 2011

Authors and Affiliations

  • Cliona Grant
    • 2
  • Kieron Dunleavy
    • 2
  • Franziska C. Eberle
    • 3
  • Stefania Pittaluga
    • 4
  • Wyndham H. Wilson
    • 2
  • Elaine S. Jaffe
    • 1
  1. 1.Hematopathology Section, Laboratory of Pathology, National Cancer InstituteNational Institutes of HealthBethesdaUSA
  2. 2.Metabolism BranchNational Cancer Institute, Center for Cancer Research, National Institutes of HealthBethesdaUSA
  3. 3.Department of DermatologyEberhard Karls University of TuebingenTuebingenGermany
  4. 4.Laboratory of Pathology, National Cancer InstituteCenter for Cancer Research, National Institutes of HealthBethesdaUSA